Family Office Of America (FOFA) Free Cash Flow (2021 - 2026)
Family Office Of America recorded quarterly Free Cash Flow of $225707.0 in Q1 2026, up 240.02% quarter-over-quarter from -$161200.0 in Q4 2025, and up 1066.05% year-over-year from $19356.6 in Q1 2025.
Family Office Of America's Free Cash Flow history runs 6 years deep, the most recent figure standing at $225707.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 1066.05% year-over-year to $225707.0; the TTM figure through Mar 2026 stood at -$13117.0 (up 87.0% YoY), while the FY2025 annual figure was -$262188.0, down 193.37% from the prior year.
- Free Cash Flow came in at $225707.0 for Q1 2026 at Family Office Of America, up from -$161200.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $225707.0 in Q1 2026 to a low of -$172198.0 in Q2 2022.
- A 5-year average of -$44753.3 and a median of -$27615.0 in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 424.04% in 2024 and soared 1066.05% in 2026, its largest moves.
- Family Office Of America's Free Cash Flow stood at -$102094.0 in 2022, then jumped by 92.16% to -$8002.0 in 2023, then sank by 313.87% to -$33118.0 in 2024, then tumbled by 386.74% to -$161200.0 in 2025, then surged by 240.02% to $225707.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $225707.0, -$161200.0, and -$17675.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 225,707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225,707.00 |
| Mar 31, 2026 | 225,707.00 |
| Dec 31, 2025 | -161,200.00 |
| Dec 31, 2025 | -161,200.00 |
| Sep 30, 2025 | -17,675.00 |
| Sep 30, 2025 | -17,675.00 |
| Jun 30, 2025 | -59,949.00 |
| Jun 30, 2025 | -59,949.00 |
| Mar 31, 2025 | -23,364.00 |
| Mar 31, 2025 | -23,364.00 |
| Dec 31, 2024 | -33,118.00 |
| Dec 31, 2024 | -33,118.00 |
| Sep 30, 2024 | -16,777.00 |
| Sep 30, 2024 | -16,777.00 |
| Jun 30, 2024 | -27,615.00 |
| Jun 30, 2024 | -27,615.00 |
| Mar 31, 2024 | -11,860.00 |
| Mar 31, 2024 | -11,860.00 |
| Dec 31, 2023 | -8,002.00 |
| Dec 31, 2023 | -8,002.00 |
| Sep 30, 2023 | -23,296.00 |
| Sep 30, 2023 | -23,296.00 |
| Jun 30, 2023 | 8,522.00 |
| Jun 30, 2023 | 8,522.00 |
| Mar 31, 2023 | -53,753.00 |
| Mar 31, 2023 | -53,753.00 |
| Dec 31, 2022 | -102,094.00 |
| Dec 31, 2022 | -102,094.00 |
| Sep 30, 2022 | -154,335.00 |
| Sep 30, 2022 | -154,335.00 |
| Jun 30, 2022 | -172,198.00 |
| Jun 30, 2022 | -172,198.00 |
| Mar 31, 2022 | -129,799.00 |
| Mar 31, 2022 | -129,799.00 |
| Dec 31, 2021 | -175,637.00 |
| Dec 31, 2021 | -175,637.00 |
| Sep 30, 2021 | -357,987.00 |
| Sep 30, 2021 | -357,987.00 |